Insider Selling: Molina Healthcare, Inc. (MOH) Director Sells 16,226 Shares of Stock

Molina Healthcare, Inc. (NYSE:MOH) Director John C. Molina sold 16,226 shares of the firm’s stock in a transaction that occurred on Thursday, January 18th. The stock was sold at an average price of $92.49, for a total value of $1,500,742.74. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

John C. Molina also recently made the following trade(s):

  • On Monday, December 18th, John C. Molina sold 19,885 shares of Molina Healthcare stock. The stock was sold at an average price of $75.47, for a total value of $1,500,720.95.

Shares of Molina Healthcare, Inc. (MOH) traded down $1.94 during mid-day trading on Friday, hitting $91.83. The company’s stock had a trading volume of 1,660,272 shares, compared to its average volume of 1,479,923. Molina Healthcare, Inc. has a one year low of $42.56 and a one year high of $93.98. The stock has a market cap of $5,250.00, a P/E ratio of -17.43, a P/E/G ratio of 1.18 and a beta of 0.97. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 1.06.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Thursday, November 2nd. The company reported ($1.62) earnings per share for the quarter, missing the consensus estimate of $0.23 by ($1.85). Molina Healthcare had a negative net margin of 1.76% and a positive return on equity of 17.76%. The company had revenue of $5.03 billion during the quarter, compared to analysts’ expectations of $4.95 billion. During the same quarter last year, the business posted $0.85 earnings per share. The company’s revenue for the quarter was up 10.7% compared to the same quarter last year. research analysts expect that Molina Healthcare, Inc. will post -3.88 EPS for the current year.

A number of research analysts recently issued reports on MOH shares. Zacks Investment Research downgraded Molina Healthcare from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. Jefferies Group raised their price target on Molina Healthcare from $64.00 to $74.00 and gave the stock a “hold” rating in a research note on Friday, November 3rd. Goldman Sachs Group started coverage on Molina Healthcare in a research note on Wednesday, January 3rd. They set a “neutral” rating and a $83.00 price target on the stock. Wolfe Research upgraded Molina Healthcare from a “market perform” rating to an “outperform” rating in a research note on Monday, October 23rd. Finally, Morgan Stanley raised their price target on Molina Healthcare from $68.00 to $89.00 and gave the stock an “overweight” rating in a research note on Friday, November 3rd. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $70.86.

Hedge funds have recently made changes to their positions in the business. Cambridge Investment Research Advisors Inc. grew its stake in shares of Molina Healthcare by 33.9% in the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 8,958 shares of the company’s stock valued at $616,000 after purchasing an additional 2,266 shares during the last quarter. Tavio Capital LLC grew its stake in shares of Molina Healthcare by 418.0% in the 3rd quarter. Tavio Capital LLC now owns 537,192 shares of the company’s stock valued at $36,937,000 after purchasing an additional 433,485 shares during the last quarter. Rothschild Asset Management Inc. lifted its holdings in shares of Molina Healthcare by 6.1% in the 3rd quarter. Rothschild Asset Management Inc. now owns 706,683 shares of the company’s stock valued at $48,592,000 after buying an additional 40,737 shares during the period. Jana Partners LLC lifted its holdings in shares of Molina Healthcare by 52.5% in the 3rd quarter. Jana Partners LLC now owns 2,125,351 shares of the company’s stock valued at $146,139,000 after buying an additional 731,992 shares during the period. Finally, Legal & General Group Plc lifted its holdings in shares of Molina Healthcare by 25.8% in the 3rd quarter. Legal & General Group Plc now owns 71,545 shares of the company’s stock valued at $4,912,000 after buying an additional 14,682 shares during the period.

WARNING: This article was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://www.americanbankingnews.com/2018/01/19/insider-selling-molina-healthcare-inc-moh-director-sells-16226-shares-of-stock.html.

Molina Healthcare Company Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Insider Buying and Selling by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply